Tempest Therapeutics Inc. (TPST) is a clinical-stage biotechnology company based in South San Francisco, California, that specializes in developing innovative small molecule therapeutics that integrate targeted therapies with immune-based mechanisms to combat various oncology challenges. The company's promising pipeline is indicative of its commitment to addressing unmet needs in hard-to-treat cancer indications, positioning Tempest as a pivotal player in advancing cancer research and therapeutics. By focusing on delivering groundbreaking treatment options, Tempest is not only enhancing patient outcomes but also driving significant value for its stakeholders in the evolving landscape of oncology. Show more
Location: 2000 SIERRA POINT PARKWAY, BRISBANE, CA, UNITED STATES, 94005, Brisbane, CA, 94005, USA | Website: https://www.tempesttx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
11.92M
52 Wk Range
$2.16 - $12.37
Previous Close
$2.42
Open
$2.34
Volume
107,702
Day Range
$2.16 - $2.40
Enterprise Value
12.81M
Cash
7.514M
Avg Qtr Burn
-6.779M
Insider Ownership
0.04%
Institutional Own.
8.20%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
